loading page

Nivolumab-induced acute tubular injury: a case report
  • HUI HSIN YANG,
  • Chia-Wen Chang,
  • Tai-Di Chen
HUI HSIN YANG
Chang Gung Memorial Hospital Linkou Main Branch

Corresponding Author:[email protected]

Author Profile
Chia-Wen Chang
Chang Gung Memorial Hospital Linkou Main Branch
Author Profile
Tai-Di Chen
Chang Gung Memorial Hospital Linkou Main Branch
Author Profile

Abstract

A 58-year-old woman had gastric cancer treated with nivolumab. Her serum creatinine (Cr) increased to 5.94 mg/dL post two cycles of nivolumab and co-administered with acemetacin. A kidney biopsy showed acute tubular injury (ATI).
02 Nov 2022Submitted to Clinical Case Reports
02 Nov 2022Submission Checks Completed
02 Nov 2022Assigned to Editor
04 Nov 2022Reviewer(s) Assigned
08 Nov 2022Review(s) Completed, Editorial Evaluation Pending
29 Nov 2022Editorial Decision: Revise Minor
06 Jan 20231st Revision Received
09 Jan 2023Submission Checks Completed
09 Jan 2023Assigned to Editor
09 Jan 2023Review(s) Completed, Editorial Evaluation Pending
23 Jan 2023Editorial Decision: Accept